Bempedoic acid
Esperion
['congrat']
clear outcomes trial: in 13,970 randomized patients with statin intolerance, bempedoic acid reduced primary endpoint vs. placebo. also 48% females enrolled in the trial! another tool for us to use in this group with outcomes data. congrats to the study team! #acc23 
Preventive Cardiologist @DukeHeartCenter @DCRINews | Assistant Professor | Alum of @ClevelandClinic @HopkinsMedicine | Father and Husband | Tweets are my own